Held under the auspices of the Arab Medical Association Against Cancer (AMAAC) and the Bank of Cyprus Oncology Centre

MASTERCLASS

23-27 January 2020Limassol, Cyprus

Chairs: M.S. Aapro, CH - N. Pavlidis, GR

Co-chairs: J. Gligorov, FR - S. Khatib, JO

Host Chair: D. Papamichael, CY

8TH ESO-ESMO ARAB AND SOUTHERNEUROPEAN COUNTRIES

MASTERCLASS IN CLINICAL ONCOLOGY

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 3

AIMS AND OBJECTIVESThis clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.The programme will expose participants to a full spectrum of issues in clinical oncology and topractice-orientated training. The programme focuses on breast, gynaecological, lung, urologicaland gastrointestinal cancers. Spotlight sessions will facilitate compact update on head and neck,melanoma, elderly patients, soft tissue sarcoma, non-Hodgkin lymphoma cancer of unknownprimary, supportive care and the role of informal supporter.

TEACHING FORMATThe Masterclass offers plenary lectures discussing current issues and controversies as well ascritically reviewing significant therapeutic developments. State-of-the-art data recognized byESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.All participants will reside at the course venue and participation is compulsory throughout thecourse. The Masterclass will be entirely in English and at least an intermediate level of English isnecessary for admission.

THE MASTERCLASS:• Full immersion• 3-and-a-half-day residential event• Clinically-oriented• Multidisciplinary• An international faculty of top experts delivering lectures focusing on breast, gynaecological, lung,urological and gastrointestinal cancers.

TRAVEL SUPPORTTravel support will be made available as a contribution to travel expenses, to admitted participants coming from lower-middle- income countries as defined by the World Bank.

CERTIFICATE OF ATTENDANCE Participants will receive their certificate of attendance via e-mail after the event on completion ofthe evaluation form.The programme is furthermore accredited with 25 ESMO-MORA category 1 points.

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 4

FACULTY

M.S. Aapro, Clinique de Genolier, CH

H. Azim, Cairo University, Cairo Oncology Center, EG

H. Azim jr, American University of Beirut, LB

M.J. Cardoso, Champalimaud Foundation, Lisbon, PT

S. Cascinu, Università di Modena e Reggio Emilia, Modena, IT

G. Ceresoli, Humanitas Gavazzeni, Bergamo, IT

A. Charalambous, Cyprus University of Technology, Limassol, CY

A. Constantinidou, University of Cyprus, Medical School, Nicosia, CY

A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO

F. Geara, American University of Beirut, LB

H. Gogas, University of Athens, Athens, GR

J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR

J. Khader, King Hussein Cancer Center, Amman, JO

P. Kountourakis, Bank of Cyprus Oncology Centre, Nicosia, CY

N. Mottet, University Jean Monnet, Saint Etienne, FR

R. Orecchia, European Institute of Oncology, Milan, IT

D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY

N. Pavlidis, Ioannina School of Medicine, GR

J. Remon-Masip, Centro Integral Oncología Clara Campal (CIOCC), Barcelona, ES

A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH

S. Temraz, American University of Beirut, LB

J.B. Vermorken, Antwerp University Hospital, BE

A. Vingiani, European Institute of Oncology, Milan, IT

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 1

PROGRAMME

Thursday, 23 January

Participants’ arrival and dinner

Friday, 24 January 8:00 Registration

8:45 Welcome address M.S. Aapro, CH - N. Pavlidis, GR

UROLOGICAL CANCER SESSION Chairs: J. Khader, JO - N. Mottet, FR

9:00 Management including active surveillance of localized

prostate cancer J. Khader, JO

9:25 Discussion

9:30 Key topics in locally advanced, advanced and metastatic

prostate cancer N. Mottet, FR

9:55 Discussion

10:00 Update in the management of bladder cancer J. Khader, JO

10:25 Discussion

10:30 Coffee break

11:00 Update in the management of renal cancer N. Mottet, FR

11:25 Discussion

11:30 Management of relapsed testicular cancer S. Temraz, LB

12:00 Urological Cancer Tumor Board (4 cases)

13:00 Lunch

LUNG CANCER SESSION Chairs:G. Ceresoli, IT - F. Geara, LB

14:00 The impact of radiation therapy in lung cancer F. Geara, LB

14:25 Discussion

14:30 Neoadjuvant and adjuvant systemic treatment in NSCLC G. Ceresoli, IT

14:55 Discussion

15:00 Systemic chemotherapy and targeted treatment in

metastatic NSCLC J. Remon-Masip, ES

15:25 Discussion

15:30 Coffee break

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 5

P

R

W M

C R

M

p J

D

K

p N

D

U J

D

C

U N

D

M S

U

L

C

T F

D

N G

D

1 S

m J

D

C

16:00 Immune check point inhibitors in NSCLC J. Remon-Masip, ES

16:25 Discussion

16:30 Systemic therapy of small-cell lung cancer G. Ceresoli, IT

16:55 Discussion

17:00 Systemic management of advanced mesothelioma G. Ceresoli, IT

17:25 Discussion

17:30- Lung Cancer Tumor Board (4 cases)

18:30

20:00 Dinner

Saturday, 25 January GASTROINTESTINAL CANCER SESSION Chairs: P. Kountourakis CY

S. Cascinu, IT

8:30 Adjuvant/neoadjuvant systemic treatment in

colorectal cancer P. Kountourakis CY

8:55 Discussion

9:00 Systemic treatment in advanced colon cancer S. Cascinu, IT

9:25 Discussion

9:30 Radiation treatment in rectal cancer J. Khader, JO

9:55 Discussion

10:00 Systemic treatment in early and advanced gastric

cancer S. Cascinu, IT

10:25 Discussion

10:30 Coffee break

11:00 Gastrointestinal Cancer Tumor Board (4 cases)

12:00 Lunch

SPOTLIGHT SESSIONS 1

13:00 Modern management of melanoma H. Gogas, GR

13:25 Discussion

13:30 Cancer of unknown primary N. Pavlidis, GR

13:55 Discussion

14:00 How do I manage cancer in elderly patients M.S. Aapro, CH

14:25 Discussion

14:30 The role of informal supporter A. Charalambous, CY

14:50 Discussion

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 6

15:00 Update in the management of high-grade NHL A. Stathis, CH

15:25 Discussion

15:30 Coffee break

16:00 - Parallel Group Sessions I (Cases discussion in three groups)

17:30

Sunday, 26 January BREAST CANCER SESSION Chairs: J. Gligorov, FR - H. Azim, EG

8:30 What the clinician needs to know from the breast

pathologist A. Vingiani, IT

8:55 Discussion

9:00 Current controversies/challenges in breast surgery M.J. Cardoso, PT

9:25 Discussion

9:30 The role of radiotherapy in early and locally advanced

breast cancer R. Orecchia, IT

9:55 Discussion

10:00 Genomic testing in breast cancer H. Azim jr, LB

10:25 Discussion

10:30 Coffee break

11:00 Neoadjuvant/adjuvant chemotherapy and biological

agents A. Eniu, RO

11:25 Discussion

11:30 Neoadjuvant/adjuvant endocrine therapy J. Gligorov, FR

11:55 Discussion

12:00 Management of HER2+ advanced breast cancer A. Eniu, RO

12:25 Discussion

12:30 Management of triple-negative advanced breast cancer H. Azim, EG

12:55 Discussion

13:00 Management of ER+ advanced breast cancer J. Gligorov, FR

13:25 Discussion

13:30 Lunch

14:30 Breast Cancer Tumor Board (4 cases)

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 7

SPOTLIGHT SESSIONS 2

15:30 Supportive care M.S. Aapro, CH

15:55 Discussion

16:00 Update in the management of soft tissue sarcomas A. Constantinidou, CY

16:25 Discussion

16:30 Coffee break

17:00- Parallel Group Sessions II (Case discussion in three groups) 18:30

Monday, 27 January GYNECOLOGICAL CANCER SESSION Chairs: A. Constantinidou, CY

J.B. Vermorken, BE

8:00 Systemic management of ovarian cancer J.B. Vermorken, BE

8:25 Discussion

8:30 Systemic management of locally advanced or

metastatic cervical and endometrial cancer J.B. Vermorken, BE

8:55 Discussion

9:00 Gynecological Cancer Tumor Board (4 cases)

10:00 Coffee break

SPOTLIGHT SESSIONS 3

10:30 Update in the management of head and neck cancer J.B. Vermorken, BE

10:55 Discussion

11:00 Learning Self-Assessment Test

11:45 Closing remarks and awards

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 8

European School of Oncology

WWW.ESO.NETeso@eso.net

Piazza Indipendeza 26500 Bellinzona, Switzerland

Tel: +41 91 820 09 50 Fax: +41 91 820 09 53

Via Turati, 2920121 Milan, ItalyTel: +39 02 8546451 Fax: +39 02 85464545

MCO Limassol (13 Jan)_screen 13.01.2020 10:51 Pagina 2